TrialFrontiers in immunology2021

Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial.

David A Bernal-Estévez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.